Advanced glycation end-products: modifiable environmental factors profoundly mediate insulin resistance-Reference-Cited by-同舟云学术

Advanced glycation end-products: modifiable environmental factors profoundly mediate insulin resistance

Published:2015 Issue:1 Volume:57 Page:1-12
ISSN:0912-0009
Container-title:Journal of Clinical Biochemistry and Nutrition
language:en
Short-container-title:J. Clin. Biochem. Nutr.

Author:

Ottum Mona S.¹,Mistry Anahita M.¹

Affiliation:

1. Dietetics and Human Nutrition Program, 318 Marshall Building, Eastern Michigan University

Publisher

The Society for Free Radical Research Japan

Subject

Clinical Biochemistry,Nutrition and Dietetics,Medicine (miscellaneous)

Reference184 articles.

1. 1 Johnson NB, Hayes LD, Brown K, Hoo EC, Ethier KA; Centers for Desease Control and Prevention (CDC). CDC National Health Report: leading causes of morbidity and mortality and associated behavioral risk and protective factors--United States, 2005–2013. MMWR Surveill Summ 2014; 63 Suppl 4: 3–27.

2. 2 Thorpe KE. Treated disease prevalence and spending per treated case drove most of the growth in health care spending in 1987–2009. Health Aff (Millwood) 2013; 32: 851–858.

3. 3 Hellgren MI, Daka B, Jansson PA, Lindblad U, Larsson CA. Insulin resistance predicts early cardiovascular morbidity in men without diabetes mellitus, with effect modification by physical activity. Eur J Prev Cardiol 2014. DOI: 10.1177/2047487314537917

4. 4 Morris JK, Vidoni ED, Perea RD, et al. Insulin resistance and gray matter volume in neurodegenerative disease. Neuroscience 2014; 270: 139–147.

5. 5 Krentz AJ, Viljoen A, Sinclair A. Insulin resistance: a risk marker for disease and disability in the older person. Diabet Med 2013; 30: 535–548.

Cited by 71 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Treatment of Acute and Long-COVID, Diabetes, Myocardial Infarction, and Alzheimer’s Disease: The Potential Role of a Novel Nano-Compound—The Transdermal Glutathione–Cyclodextrin Complex;Antioxidants;2024-09-12

2. Advanced Glycation End-Products Acting as Immunomodulators for Chronic Inflammation, Inflammaging and Carcinogenesis in Patients with Diabetes and Immune-Related Diseases;Biomedicines;2024-07-31

3. Galectin-3 protects distal convoluted tubules in rhabdomyolysis-induced kidney injury;Pflügers Archiv - European Journal of Physiology;2024-07-23

4. Insulin resistance as the molecular link between diabetes and Alzheimer's disease;World Journal of Diabetes;2024-07-15

5. Elucidation of inhibitory effects of bioactive anthraquinones towards formation of DNA advanced glycation end products (DNA-AGEs);International Journal of Biological Macromolecules;2024-06